Identifying the Right Investigators and Patients for your Study – Mini Podcast Biosimilar Development Capabilities – Watch Now Vaccine Development Capabilities - Brochure Check out our latest Validated PK & ADA Methods List Read about Veeda's partnership with Ahammune Biosciences for first in human studies Check out our Assay List (Method Library)
Webinar on

Advanced Strategies in Bioanalysis of Biosimilars: Achieving Similarity through Robust Assays

25th July, 2024

18:00 IST | 14:30 CET | 08:30 EDT

In this webinar, you will get to know:

  • Impact of the bioanalytical assay set-up on the clinical endpoints
  • Understand the rationale behind the one-assay approach
  • Get insight into how critical reagents can impact assay
  • Regulatory considerations and expectations


Dr Jagadeesh Boda

General Manager and Head, Clinical Bioanalysis, Veeda Clinical Research Ltd (Biopharma Division)

Dr. Jagadeesh Boda serves as the General Manager and oversees the Clinical Bioanalysis Department at Veeda Clinical Research Ltd, Biopharma Division, a contract research organization specializing in supporting biotherapeutics drug development. With a PhD in Pharmaceutical Sciences, he boasts over 17 years of experience as a scientific leader in regulated bioanalysis across various sectors including pharmaceuticals, biotechnology, and vaccines. In his current capacity, Dr. Boda spearheads the development and validation of methods for large molecules, as well as the analysis of samples using sophisticated techniques such as chromatography and ligand binding assays. Operating within a highly regulated and GCLP compliant laboratory, he plays a pivotal role in ensuring the quality and accuracy of bioanalytical processes.

Register for webinar now!